发明名称 EP4 receptor antagonists
摘要 Compounds of formula (I): wherein: R2 is H or an optionally substituted C1-4 alkyl group; Y is either -(CH2)n-X-, where n is 1 or 2 and X is O, S, S(-O), S(-O)2, or NRN1, where RN1 is selected from H or optionally substituted C1-4 alkyl, or Y is -C(-O)NRN2-, where RN2 is selected from H, and optionally substituted C1-7 alkyl or C5-20 aryl; R3 is an optionally substituted C6 aryl group linked to a further optionally substituted C6 aryl group, wherein if both C6 aryl groups are benzene rings, there may be an oxygen bridge between the two rings, bound adjacent the link on both rings; A is a single bond or a C1-3 alkylene group; and R5 is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C1-7 alkyl, C5-20 aryl or NRN3RN4, where RN3 and RN4 are independently selected from optionally substituted C1-4 alkyl; (iv) tetrazol-5-yl.
申请公布号 US7528157(B2) 申请公布日期 2009.05.05
申请号 US20060615024 申请日期 2006.12.22
申请人 ASTERAND UK LIMITED 发明人 OXFORD ALEXANDER W.;DAVIS RICHARD J.;COLEMAN ROBERT A.;CLARK KENNETH L.;CLARK DAVID E.;HARRIS NEIL V.;FENTON GARRY;HYND GEORGE;STUTTLE KEITH A. J.;SUTTON JONATHAN M.;NEWTON CHRISTOPHER G.
分类号 C07D307/68;A61K31/34;A61K31/443;C07D307/54;C07D307/64;C07D405/10;C07D405/12;C07D407/12;C07D409/12;C07D417/12;C07D417/14 主分类号 C07D307/68
代理机构 代理人
主权项
地址